RecruitingPhase 2NCT07419373
ARN-75039 Lassa Fever Treatment in West Africa
Studying Lassa fever
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Arisan Therapeutics, Inc.
- Principal Investigator
- Ken McCormack, PhDArisan Therapeutics, Inc.
- Intervention
- ARN-75039 high(drug)
- Enrollment
- 135 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2026 – 2027
Study locations (4)
- Arisan Therapeutics, Carlsbad, California, United States
- Federal Medical Centre, Owo, Owo, Ondo State, Nigeria
- Abubakar Tafawa Balewa University Teaching Hospital, Bauchi, Nigeria
- Irrua Specialist Teaching Hospital, Irrua, Nigeria
Collaborators
Irrua Specialist Teaching Hospital · Bernhard Nocht Institute for Tropical Medicine · Federal Medical Centre, Owo · ANRS, Emerging Infectious Diseases · Battelle Memorial Institute · JPEO, Chemical, Biological, Radiological, and Nuclear, Medical · Alliance for International Medical Action
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07419373 on ClinicalTrials.govOther trials for Lassa fever
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2, PHASE3NCT06212336ISTH/ANRS 0409s INTEGRATE Lassa Fever StudyIrrua Specialist Teaching Hospital
- ACTIVE NOT RECRUITINGPHASE1NCT06546709DMID 23-0015; Lassa Fever CVD 1000Wilbur Chen, MD, MS
- RECRUITINGPHASE2NCT05868733A Lassa Fever Vaccine Trial in Adults and Children Residing in West AfricaInternational AIDS Vaccine Initiative
- RECRUITINGPHASE2NCT06222723LAssa Fever Adjunct Treatment With DEXamethasoneBernhard Nocht Institute for Tropical Medicine
- ACTIVE NOT RECRUITINGNCT03655561Lassa Fever Clinical Course and Prognostic Factors in NigeriaAlliance for International Medical Action